CHU de Quebec-Universite Laval
Quick facts
Marketed products
- 4CMenb · Immunology / Infectious Disease
4CMenb is a meningococcal serogroup B conjugate vaccine that stimulates immune responses against Neisseria meningitidis serogroup B. - Acetylsalicylic Acid 80 mg
- Anti-TNFα continued perioperatively
- Anti-TNF suspended perioperatively
- Brand-name latanoprost · Ophthalmology
Latanoprost is a prostaglandin F analog that binds to the prostaglandin F (FP) receptor to increase uveoscleral outflow of aqueous humor, thereby lowering intraocular pressure. - Generic latanoprost · Ophthalmology
Latanoprost is a prostaglandin F analog that binds to prostaglandin F receptors in the eye to increase uveoscleral outflow of aqueous humor, thereby lowering intraocular pressure. - Monthly antibiotic · Infectious Disease
A monthly antibiotic that provides extended-duration antimicrobial coverage through sustained-release formulation or long-acting delivery. - PrEP using Truvada
- SASS · Other
- Vitamin D chewable tablet supplementation · Nutritional supplementation / Bone health
Vitamin D supplementation provides cholecalciferol (vitamin D3) to maintain adequate serum vitamin D levels, supporting calcium absorption and bone health. - Vitamin D pill supplementation · Nutritional supplementation / Bone health / Immunology
Vitamin D supplementation increases circulating 25-hydroxyvitamin D levels to support calcium homeostasis, bone health, and immune function.
Phase 3 pipeline
- Bifilact® · Gastroenterology
Bifilact is a probiotic therapeutic that restores beneficial bacterial flora to treat or prevent gastrointestinal and related disorders. - Enzalutamide capsule · Oncology
Enzalutamide is an androgen receptor inhibitor that blocks the binding and nuclear translocation of androgens, preventing androgen-driven gene transcription in prostate cancer cells. - pr Sandoz Tamsulosin · Urology
Tamsulosin is an alpha-1 adrenergic receptor antagonist that relaxes smooth muscles in the prostate and bladder neck, improving urine flow.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- CHU de Quebec-Universite Laval portfolio CI brief
- CHU de Quebec-Universite Laval pipeline updates RSS
Frequently asked questions about CHU de Quebec-Universite Laval
What are CHU de Quebec-Universite Laval's marketed drugs?
Top marketed products include 4CMenb, Acetylsalicylic Acid 80 mg, Anti-TNFα continued perioperatively, Anti-TNF suspended perioperatively, Brand-name latanoprost, Generic latanoprost.
What is CHU de Quebec-Universite Laval's pipeline?
CHU de Quebec-Universite Laval has 3 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Bifilact®, Enzalutamide capsule, pr Sandoz Tamsulosin.
Related
- 4CMenb · Immunology / Infectious Disease
- Acetylsalicylic Acid 80 mg
- Anti-TNFα continued perioperatively
- Anti-TNF suspended perioperatively
- Brand-name latanoprost · Ophthalmology
- Sector hub: All tracked pharma companies